<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article
  PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">OTO</journal-id>
<journal-id journal-id-type="hwp">spoto</journal-id>
<journal-title>Otolaryngology–Head and Neck Surgery</journal-title>
<issn pub-type="ppub">0194-5998</issn>
<issn pub-type="epub">1097-6817</issn>
<publisher>
<publisher-name>SAGE Publications</publisher-name>
<publisher-loc>Sage CA: Los Angeles, CA</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.1177/0194599811421751</article-id>
<article-id pub-id-type="publisher-id">10.1177_0194599811421751</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Case Reports</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Sinonasal Hemangiopericytoma in the Columellar Base, an Unusual Location</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" corresp="yes">
<name><surname>Pfammatter</surname><given-names>Alain</given-names></name>
<degrees>MD</degrees>
<xref ref-type="aff" rid="aff1-0194599811421751">1</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Brändle</surname><given-names>Peter</given-names></name>
<degrees>MD</degrees>
<xref ref-type="aff" rid="aff1-0194599811421751">1</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Hürlimann</surname><given-names>Sandra</given-names></name>
<degrees>MD</degrees>
<xref ref-type="aff" rid="aff2-0194599811421751">2</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Schlegel-Wagner</surname><given-names>Christoph</given-names></name>
<degrees>MD</degrees>
<xref ref-type="aff" rid="aff1-0194599811421751">1</xref>
</contrib>
</contrib-group>
<aff id="aff1-0194599811421751"><label>1</label>Department of Otorhinolaryngology, Head &amp; Neck Surgery, Luzerner Kantonsspital, Lucerne, Switzerland</aff>
<aff id="aff2-0194599811421751"><label>2</label>Departement of Pathology, Luzerner Kantonsspital, Lucerne, Switzerland</aff>
<author-notes>
<corresp id="corresp1-0194599811421751">Alain Pfammatter, MD, Department of Otorhinolaryngology, Luzerner Kantonsspital, Spitalstrasse 16, 6000 Lucerne, Switzerland Email: <email>alainpfammatter@hotmail.com</email></corresp>
</author-notes>
<pub-date pub-type="epub-ppub">
<month>4</month>
<year>2012</year>
</pub-date>
<volume>146</volume>
<issue>4</issue>
<fpage>682</fpage>
<lpage>683</lpage>
<history>
<date date-type="received">
<day>22</day>
<month>6</month>
<year>2011</year>
</date>
<date date-type="rev-recd">
<day>3</day>
<month>8</month>
<year>2011</year>
</date>
<date date-type="accepted">
<day>8</day>
<month>8</month>
<year>2011</year>
</date>
</history>
<permissions>
<copyright-statement>© American Academy of Otolaryngology—Head and Neck Surgery Foundation 2012</copyright-statement>
<copyright-year>2012</copyright-year>
<copyright-holder content-type="society">Official journal of the American Academy of Otolaryngology–Head and Neck Surgery Foundation</copyright-holder>
</permissions>
<kwd-group>
<kwd>sinonasal hemangiopericytoma</kwd>
<kwd>hemangiopericytoma columellar base</kwd>
<kwd>hemangiopericytoma unusual location</kwd>
</kwd-group>
</article-meta>
</front>
<body>
<p>Hemangiopericytomas can be found throughout the whole human body. Approximately 15% to 25% of hemangiopericytomas arise in the head and neck.<sup><xref ref-type="bibr" rid="bibr1-0194599811421751">1</xref>,<xref ref-type="bibr" rid="bibr2-0194599811421751">2</xref></sup> The sinonasal-type hemangiopericytoma has to be distinguished from the classical hemangiopericytoma, which mainly occurs in the buccal mucosa or tongue and presents nowadays a reclassified separate entity with a different cell of origin, clinic, morphology, and biology.<sup><xref ref-type="bibr" rid="bibr1-0194599811421751">1</xref></sup> This sinonasal-type hemangiopericytoma is the most common manifestation usually located in the nasal cavity and paranasal sinus.<sup><xref ref-type="bibr" rid="bibr1-0194599811421751">1</xref>-<xref ref-type="bibr" rid="bibr3-0194599811421751">3</xref></sup> It remains a rare tumor, accounting for fewer than 1% of sinonasal tumors, and it behaves usually in a benign matter. Patients mostly present with airway obstruction and/or epistaxis and are between 60 and 70 years old with a slightly female predominance.<sup><xref ref-type="bibr" rid="bibr3-0194599811421751">3</xref></sup> We present the first case, to our knowledge, of a histologically sinonasal-type hemangiopericytoma not located in the sinonasal system but rather in the upper lip.</p>
<sec id="section1-0194599811421751" sec-type="cases">
<title>Case Report</title>
<p>A 45-year-old woman was referred to our ENT department with a 1-year history of a slow-growing, painless mass of soft consistency in the junction between the columella and the upper lip (<bold><xref ref-type="fig" rid="fig1-0194599811421751">Figure 1</xref></bold>). By nasal endoscopy, no fistula from the tumor could be found in the nasal floor or the oral vestibule. A magnetic resonance imaging scan showed a well-demarcated 2-cm round tumor below the columella (<bold><xref ref-type="fig" rid="fig2-0194599811421751">Figure 2</xref></bold>). The radiologists suspected a pleomorphic adenoma. Fine-needle aspiration cytology was consistent with a neurofibroma or schwannoma. The patient underwent surgery, and the tumor was completely excised through an incision in the vestibulum oris. Intraoperatively, the lesion presented as a well-encapsulated round and bluish tumor without connection to the nasal cavity. The surgeon suspected a hemangioma. The following histopathological examination showed a nodular cell-rich mesenchymal neoplasia with spindle-shaped to round/oval cells with eosinophilic cytoplasma. The tumor was richly vascularized, including staghorn-like vessels. Immunohistology showed the lesion to be positive for actin and bcl 2 and negative for CD34, CD99, desmin, cytokeratins, S100, and EMA and with a low proliferation rate. The histomorphological and immunohistochemical findings were consistent with a hemangiopericytoma of the sinonasal type. Morphologically, no criteria for aggressive behavior of the tumor (eg, size bigger than 5 cm, nuclear polymorphism, mitoses [&gt;4/10 HPF], necrosis, or MIB1 &gt;10%) could be found. The patient recovered well without visible scars and had no dysesthesia. The patient will be followed up regularly as local recurrence rates for sinonasal hemangiopericytoma are reported up to 40%.<sup><xref ref-type="bibr" rid="bibr2-0194599811421751">2</xref></sup></p>
<fig id="fig1-0194599811421751" position="float">
<label>Figure 1.</label>
<caption><p>Preoperative photography showing the tumor below the columella.</p></caption>
<graphic xlink:href="10.1177_0194599811421751-fig1.tif"/>
</fig>
<fig id="fig2-0194599811421751" position="float">
<label>Figure 2.</label>
<caption><p>Magnetic resonance imaging T2-weighted, sagittal reconstruction showing the sharp-boarded round tumor below the columella in the upper lip.</p></caption>
<graphic xlink:href="10.1177_0194599811421751-fig2.tif"/>
</fig>
</sec>
<sec id="section2-0194599811421751" sec-type="discussion">
<title>Discussion</title>
<p>The sinonasal type hemangiopericytoma, in the current literature also called glomangiopericytoma, account for fewer than 1% of sinonasal tumors.<sup><xref ref-type="bibr" rid="bibr1-0194599811421751">1</xref></sup> Epistaxis and airway obstruction are the most common clinical presentations. Our patient presented with a hemangiopericytoma of the sinonasal type in an unusual location at the subnasale (eg, the junction between the columella and upper lip). Neither radiology nor surgery revealed any communication between the tumor and the nasal cavity. To our state of knowledge, this is the first case of a histologically sinonasal-type hemangiopericytoma located outside of the nasal cavity and sinuses with the typical histopathological features of a cellular richly vascularized tumor with staghorn-like vessels and immunohistochemical positivity for actin and bcl2 and negativity for CD34. Fortunately, no nuclear polymorphism, necrosis, or increased mitotic activity as signs for aggressive tumor behavior could be found. Sinonasal hemangiopericytoma show mainly an indolent course. But local recurrence is found in up to 40% of cases.<sup><xref ref-type="bibr" rid="bibr2-0194599811421751">2</xref></sup> Recurrence in most cases seems to be related directly to incomplete surgical removal of the tumor.<sup><xref ref-type="bibr" rid="bibr4-0194599811421751">4</xref></sup> Metastatic disease is very rare and more often seen in the nonsinonasal type.<sup><xref ref-type="bibr" rid="bibr5-0194599811421751">5</xref></sup> The mainstay treatment of sinonasal hemangiopericytoma is complete surgical excision. For tumors located in the nasal cavity and paranasal sinuses, endoscopic endonasal surgery is the state of the art.<sup><xref ref-type="bibr" rid="bibr4-0194599811421751">4</xref></sup> The role of adjuvant radiotherapy is discussed controversially and reserved for large tumors (&gt;6.5 cm), positive surgical margins, or recurrent lesions.<sup><xref ref-type="bibr" rid="bibr2-0194599811421751">2</xref>,<xref ref-type="bibr" rid="bibr5-0194599811421751">5</xref></sup> Adjuvant chemotherapy in the treatment of metastatic disease is lacking sufficient evidence of effectiveness.<sup><xref ref-type="bibr" rid="bibr2-0194599811421751">2</xref></sup> Despite its rich vascularization, preoperative angiography and embolization seem not to play a major role in the management of sinonasal hemangiopericytoma, except for very large lesions or intracranial extension.<sup><xref ref-type="bibr" rid="bibr2-0194599811421751">2</xref>,<xref ref-type="bibr" rid="bibr4-0194599811421751">4</xref></sup></p>
<p>In conclusion, sinonasal-type hemangiopericytoma can also be found outside of the nasal cavity and paranasal sinuses. The treatment is complete surgical resection because the main risk is recurrence mostly caused by incomplete tumor removal.</p>
<p>This study was approved by the Institutional Review Board of the Kantonsspital Luzern on December 8, 2010.</p>
</sec>
<sec id="section3-0194599811421751">
<title>Author Contributions</title>
<p><bold>Alain Pfammatter</bold>, corresponding author, data analysis, writing, editing; <bold>Peter Brändle</bold>, primary contact to patient, follow-up; <bold>Sandra Hürlimann</bold>, pathology part; <bold>Christoph Schlegel-Wagner</bold>, proofreading, supervision.</p>
</sec>
<sec id="section4-0194599811421751">
<title>Disclosures</title>
<p><bold>Competing interests</bold>: None.</p>
<p><bold>Sponsorships</bold>: None.</p>
<p><bold>Funding source</bold>: None.</p>
</sec>
</body>
<back>
<fn-group>
<fn fn-type="presented-at">
<p>No sponsorships or competing interests have been disclosed for this article.</p>
</fn>
</fn-group>
<ref-list>
<title>References</title>
<ref id="bibr1-0194599811421751">
<label>1.</label>
<citation citation-type="book">
<person-group person-group-type="author">
<name><surname>Barnes</surname><given-names>L</given-names></name>
<name><surname>Eveson</surname><given-names>JW</given-names></name>
<name><surname>Reichard</surname><given-names>P</given-names></name>
<name><surname>Sidransky</surname><given-names>D</given-names></name>
</person-group>. <source>Pathology and Genetics Head and Neck Tumors, WHO Classification of Tumors</source>. <publisher-loc>Geneva, Switzerland</publisher-loc>: <publisher-name>World Health Organization</publisher-name>; <year>2005</year>.</citation>
</ref>
<ref id="bibr2-0194599811421751">
<label>2.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Billings</surname><given-names>KR</given-names></name>
<name><surname>Fu</surname><given-names>YS</given-names></name>
<name><surname>Calcaterra</surname><given-names>TC</given-names></name>
<name><surname>Sercarz</surname><given-names>JA</given-names></name>
</person-group>. <article-title>Hemangiopericytoma of the head and neck</article-title>. <source>Am J Otolaryngol</source>. <year>2000</year>;<volume>21</volume>:<fpage>238</fpage>-<lpage>243</lpage>.</citation>
</ref>
<ref id="bibr3-0194599811421751">
<label>3.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Thompson</surname><given-names>LDR</given-names></name>
<name><surname>Miettinen</surname><given-names>M</given-names></name>
<name><surname>Wenig</surname><given-names>BM</given-names></name>
</person-group>. <article-title>Sinonasal-type hemangiopericytoma: a clinicopathologic and immunophenotypic analysis of 104 cases showing perivascular myoid differentiation</article-title>. <source>Am J Surg Pathol</source>. <year>2003</year>;<volume>27</volume>:<fpage>737</fpage>-<lpage>749</lpage>.</citation>
</ref>
<ref id="bibr4-0194599811421751">
<label>4.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Bignami</surname><given-names>M</given-names></name>
<name><surname>Dallan</surname><given-names>I</given-names></name>
<name><surname>Battaglia</surname><given-names>P</given-names></name>
<name><surname>Lenzi</surname><given-names>R</given-names></name>
<name><surname>Pistochini</surname><given-names>A</given-names></name>
<name><surname>Castelnuovo</surname><given-names>P</given-names></name>
</person-group>. <article-title>Endoscopic, endonasal management of sinonasal haemangiopericytoma: 12-year experience</article-title>. <source>J Laryngol Otol</source>. <year>2010</year>;<volume>124</volume>:<fpage>1178</fpage>-<lpage>1182</lpage>.</citation>
</ref>
<ref id="bibr5-0194599811421751">
<label>5.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Moriya</surname><given-names>S</given-names></name>
<name><surname>Tei</surname><given-names>K</given-names></name>
<name><surname>Notani</surname><given-names>K</given-names></name>
<name><surname>Shindoh</surname><given-names>M</given-names></name>
</person-group>. <article-title>Malignant hemangiopericytoma of the head and neck: a report of 3 cases</article-title>. <source>J Oral Maxillofac Surg</source>. <year>2001</year>;<volume>59</volume>:<fpage>340</fpage>-<lpage>345</lpage>.</citation>
</ref></ref-list>
</back>
</article>